Category: News
How community engagement in Nigeria is promoting access to tranexamic acid
Tranexamic acid is a life-saving drug shown to reduce deaths from severe bleeding after birth – postpartum haemorrhage – and is recommended by the World Health Organization (WHO).* Yet, it remains understocked in pharmacies, underused by clinicians and largely unknown to the women who need it most. Founding Director of WARDC, Dr Abiola Akiyode-Afolabi speaks
Details
Maternal health advocates in Nigeria: Meet Christianah Olanike MicTaiwo
The field officers at Women Advocates Research and Documentation Centre (WARDC) are committed to tackling maternal deaths in their communities by speaking to women and families directly about the dangers of postpartum haemorrhage. In this series, we share how WARDC’s field officers are speaking with women at the grassroots to reduce Nigeria’s high rates of
DetailsMaternal health advocates in Nigeria: Meet Ambassador Alhaji Lateef Kayode Akinborode
The field officers at Women Advocates Research and Documentation Centre (WARDC) are committed to tackling maternal deaths in their communities by speaking to women and families directly about the dangers of postpartum haemorrhage. In this series, we share how WARDC’s field officers are speaking with women at the grassroots to reduce Nigeria’s high rates of
Details
Meet the I’M WOMAN Trial team: Leyla Constantino
Clinical Trial Assistant Leyla Constantino is one of the newest members of the I’M WOMAN Trial team. Before joining the team, she studied midwifery at the University of Leeds, which led her to work as a clinical trial assistant at Calderdale and Huddersfield NHS Foundation Trust (CHFT) on the reproductive health and childbirth portfolio. What
Details
Three ways that TXA can cut severe bleeding and save blood stocks
Blood being arranged for transfusion for Nosheela as she suffers from severe postpartum haemorrhaging at Holy Family Hospital on March 12, 2019 in Rawalpindi, Pakistan. Saiyna Bashir © Wellcome Trust 14 June is World Blood Donor Day. Stable supplies of safe blood allow healthcare systems to be better equipped to handle obstetric health crises, including
DetailsInternational Clinical Trials Day: An interview with I’M WOMAN Trial nurse Sumaira
The I’M WOMAN Trial team includes many nurses as we assess whether giving intramuscular tranexamic acid is as effective as giving it intravenously. Nurses are critical to the trial team – they ensure the safety of women involved in the trial, record their data and address any health concerns women may have before participating. Sumaira
DetailsFrom nursing to clinical research: interview with Professor Haleema Shakur-Still
On International Nurses’ Day, 12 May, the I’M WOMAN Trial team highlight the importance of nursing in clinical research to improve maternal health outcomes worldwide. In this interview, Professor Haleema Shakur-Still, Emeritus Professor of Global Health Clinical Trials and Co-Principal Investigator of the WOMAN-2 Trial, reflects on her nursing experiences and how it has influenced
Details
How a simpler way to treat postpartum haemorrhage could improve maternal healthcare in communities
In celebration of International Day of the Midwife, 5 May, we show how midwives are critical in every crisis that women may face when giving birth in their communities. Midwives are trusted and well-known in their communities for providing emergency obstetric care. Administering a life-saving drug like tranexamic acid intramuscularly would significantly enhance their ability
Details
The I’M WOMAN Trial team celebrates recruiting 10,000 women
The I’M WOMAN Trial teams in Nigeria, Pakistan and Tanzania have recruited a total of 10,000 women. The trial is currently one third of the way to achieving its target of 30,000 women. The I’M WOMAN Trial is recruiting women to explore faster, simpler ways to give tranexamic acid (TXA) to reduce postpartum haemorrhage –
DetailsThe I’M WOMAN Trial assess the benefits of intramuscular TXA in Tanzania
The I’M WOMAN Trial team at LSHTM visited Tanzania in October 2024. The trial is collaborating with the University of Dar es Salaam, Tanzania’s National Coordinating Centre for the trial, alongside six regional referral hospitals, two regional hospitals and one national hospital. Dr Amy Brenner, Principal Investigator of the I’M WOMAN Trial at LSHTM, said:
Details- 1
- 2
